1-3 of 3
Maxime Bucci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Persistence of Mutations in Complete Remission Including DNMT3A , TET2 and ASXL1 Mutations Is Associated with Worse Prognosis in Patients with Acute Myeloid Leukemia Treated in ALFA 0702 Study

Pierre Hirsch, Jérôme Lambert, Maxime Bucci, Caroline Deswarte, Juliette Lambert, Laurène Fenwarth, Herve Dombret, Nicolas Duployez, Claude Preudhomme, Raphael Itzykson, Francois Delhommeau
Journal: Blood
Blood (2022) 140 (Supplement 1): 549–550.
https://doi.org/10.1182/blood-2022-166713
Published: 2022
Journal Articles

Molecular Profiling Defines Distinct Prognostic Subgroups in Chilhood Acute Myeloid Leukemia: A Report from the French ELAM02 Study Group

Alice Marceau-Renaut, PharmD, Nicolas Duployez, PharmD, PhD, Benoit Ducourneau, PharmD, Myriam Labopin, MD, Arnaud Petit, MD PhD, Alexandra Rousseau, Sandrine Geffroy, PhD, Maxime Bucci, Wendy Cuccuini, Odile Fenneteau, MD, Brigitte Nelken, MD, Stéphane Ducassou, MD, Virginie Gandemer, MDPhD, Thierry Leblanc, MD, Gerard Michel, MD, Yves Bertrand, MD, Andre Baruchel, MD, Guy Leverger, MD PhD, Claude Preudhomme, PharmD, PhD, Hélène Lapillonne, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 403.
https://doi.org/10.1182/blood.V130.Suppl_1.403.403
Published: 2017
Journal Articles

Comprehensive mutational profiling of core binding factor acute myeloid leukemia

Nicolas Duployez, Alice Marceau-Renaut, Nicolas Boissel, Arnaud Petit, Maxime Bucci, Sandrine Geffroy, Hélène Lapillonne, Aline Renneville, Christine Ragu, Martin Figeac, Karine Celli-Lebras, Catherine Lacombe, Jean-Baptiste Micol, Omar Abdel-Wahab, Pascale Cornillet, Norbert Ifrah, Hervé Dombret, Guy Leverger, Eric Jourdan, Claude Preudhomme
Journal: Blood
Blood (2016) 127 (20): 2451–2459.
https://doi.org/10.1182/blood-2015-12-688705
Published: 2016
Includes: Supplemental data